# Peptide-drug-conjugates for Personalized, Targeted Therapy of Chronic Lymphocytic Leukemia

> **NCT02828774** · — · UNKNOWN · sponsor: **Assuta Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- CLL

## Interventions

- **OTHER:** there will be no intervention.

## Key facts

- **NCT ID:** NCT02828774
- **Lead sponsor:** Assuta Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2019-06
- **Final completion:** 2020-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02828774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02828774, "Peptide-drug-conjugates for Personalized, Targeted Therapy of Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02828774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*